anx_I__para

91/666/EEC: Council Decision of 11 December 1991 establishing Community reserves of foot-and-mouth disease vaccines · European Union

Quantities and sub-types of antigen to be held in the antigen banks Potent, well-tested vaccine strains corresponding to: O1 European strain O2 Middle East strain A5 European strain A24 South American strain A Middle East strain C1 European strain ASIA1 SAT2 SAT1 A recent type A strain like A/87 Argentina should be included in the collection of strains. The above strains shall be kept in quantities sufficient to provide at least five million doses of each sub-type. Each dose should have an observed potency of 6 PD50 in cattle, when tested according to the European Pharmacopoeia.

← ANNEX I · All articles · ANNEX II →

Source: EUR-Lex (Cellar) · retrieved 2026-11-08 · Text as adopted (Official Journal); later amendments are not incorporated in this text.